Navigation Links
Neuralstem ALS trial in multiple presentations at upcoming American Academy of Neurology meeting
Date:4/6/2011

ROCKVILLE, April 6, Maryland, 2011 Neuralstem, Inc. (NYSE Amex: CUR) announced that the Phase I safety trial of its human spinal cord stem cells (HSSCs) in amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease) is the subject of three presentations at the American Academy of Neurology (AAN) Annual Meeting, April 9-16th, in Honolulu, HI (http://www.aan.com/go/am11). Chief among these will be a presentation by Eva Feldman, M.D., Ph.D., who is an unpaid consultant to Neuralstem and the Principal Investigator in the ongoing ALS trial, entitled: "A Phase I, Open-Label, First-In-Human Feasibility and Safety Study of Human Spinal Cord-Derived Neural Stem Cell Transplantation for the Treatment of Amyotrophic Lateral Sclerosis," at 2:00 PM, April 11th, (http://www.abstracts2view.com/aan/view.php?nu=AAN11L_P01.287). Dr. Feldman, who is also Director of the A. Alfred Taubman Medical Research Institute and Director of Research of the ALS Clinic at the University of Michigan Health System, will present interim safety data on the first nine patients in the study.

Dr. Feldman's presentation was also chosen to be highlighted in the "Scientific Program Highlights Plenary Session" mediated by the Chair of the AAN Science Committee at 5:15 on April 15th. Inclusion in this session is by invitation only; Dr. Feldman's presentation was considered by the committee to be in the top 5% of submitted abstracts, which numbered in the thousands.

"We are thrilled to receive this level of interest and review from our peers at this prestigious neurology conference," Dr. Feldman commented. "As a doctor who sees ALS patients in the clinic, I am particularly eager to share this promising research with the scientists and clinicians of the American Academy of Neurology who continue to battle this difficult disease for their patients."

In addition
'/>"/>

Contact: Deanne Eagle
deanneeagle@gmail.com
917-837-5866
Neuralstem, Inc.
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Neuralstem files FDA application for first drug therapy
2. Neuralstem updates ALS clinical trial progress
3. Neuralstem chief scientific officer to take part in World Stem Cell Summit plenary session
4. Neuralstem stem cells survive and differentiate into neurons in rats with stroke
5. Neuralstem files FDA application for first chronic spinal cord injury stem cell trial
6. Neuralstem updates clinical trial progress
7. Fred Hutchinson Cancer Research Center to lead Immunotherapy Clinical Trials Network
8. Diabetes treatment may also provide protection against endometrial cancer
9. For Lung Disorder, Spiriva Beat Serevent in Head-to-Head Trial
10. Clinical trial seeks to determine whether platelet-rich plasma can ease the pain of osteoarthritis
11. Jefferson clinical trial: Can a cholesterol drug prevent colon cancer?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... ... 29, 2015 , ... According to the The Media Post on ... to advertisements, for medicinal use are more likely to abuse the substance. A recent ... marijuana is considered beneficial are more apt to use the substance, as opposed to ...
(Date:7/29/2015)... ... July 29, 2015 , ... Angelo’s FabriClean, an area rug cleaning company ... restoration of carpets and rugs. The company will now reverse the damage caused by ... , An overflowing overhead tank, rain leaking through an accidently left open window or ...
(Date:7/29/2015)... ... July 29, 2015 , ... More than 28,000 students in ... children living with autism will converge upon Penn State to share the latest ... National Autism Conference will be held Aug. 3-6 at the Penn Stater Conference ...
(Date:7/29/2015)... , ... July 29, 2015 , ... ... a sponsor, with its Topricin® Pain Relief and Healing Cream designated as the ... web-based organization that is actively addressing Line of Duty Deaths (LODD) and the ...
(Date:7/29/2015)... ... July 29, 2015 , ... This year, the threat of flooding is higher ... where there is water, mold is not far behind. Paul Davis, a leading provider ... water and mold damage. Paul Davis is regularly called on to handle these types ...
Breaking Medicine News(10 mins):Health News:New Study Reveals Teens Use Marijuana More in States Where Marijuana Is Legalized 2Health News:New Study Reveals Teens Use Marijuana More in States Where Marijuana Is Legalized 3Health News:Angelo’s FabriClean Now Offers Water Damage Restoration For Residential and Commercial Accounts 2Health News:Penn State Conference to Address Instruction, Success for Children with Autism 2Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 2Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 3Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 4Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 5Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 6Health News:Paul Davis Offers Tips to Minimize Property Damage and Health Risks This Flood Season 2Health News:Paul Davis Offers Tips to Minimize Property Damage and Health Risks This Flood Season 3
... ... patients who has undergone massive weight loss and now is preparing for plastic reconstructive surgery. ... , ... 25, 2009 -- Bariatric Advantage is excited to announce that the “re-launch of ProMend ...
... ... purchase of PHYTO-C SKINCARE products will not implicate the purchaser in any lawsuit or ... , ... September 25, 2009 -- PhytoCeuticals, Inc., the highly respected developer and manufacturer of proprietary ...
... to diet and weight are shaped by their social class, ... Research Council. Policymakers have long insisted on the ... this is the first study to show how everyday practices ... the diet, weight and health of teenagers. ,It is ...
... malformation, researchers find , THURSDAY, Sept. 24 (HealthDay ... first three months of pregnancy may have a slightly ... defects. , Septal heart defects -- malformations in the ... the left -- were more common among women taking ...
... ... signed two new dealer partnerships with Freedom Mobility Aids and Handicap Conversions, now offering ... provides customizable wheelchair accessible vans, known as AdaptaVans, tailored to the needs of physically ... ...
... , WASHINGTON, Sept. 24 The American Red Cross ... that even though flood waters are slowly receding, many are still unable ... (Logo: http://www.newscom.com/cgi-bin/prnh/20090108/RedCrossLOGO ) , , ... Emergency Response Vehicles (ERVs) in the area with more on standby. ...
Cached Medicine News:Health News:Bariatric Advantage Re- Launches ProMend ABG Designed to Nutritionallly Support Pre and Post Plastic Reconstructive Surgery Patient 2Health News:Purchase PHYTO-C Skincare Will Not Implicate in the Lawsuit 2Health News:Social background weighs heavily on teenage diet 2Health News:Antidepressants Linked to Heart Defects in Newborns 2Health News:Antidepressants Linked to Heart Defects in Newborns 3Health News:AdaptaVan, LLC Signs Two New Dealers: Company's Wheelchair Accessible Vans Now Available in North Carolina and Missouri 2Health News:Red Cross Lending a Hand to Flood Victims Unable to Go Home 2Health News:Red Cross Lending a Hand to Flood Victims Unable to Go Home 3
(Date:7/29/2015)... , July 27, 2015 Research ... addition of the "Global Neurostimulation Devices Market ... The analysts forecast the global neurostimulation devices market ... the period 2014-2019. The report, Global ... on an in-depth market analysis with inputs from ...
(Date:7/29/2015)... , July 29, 2015 The Judicial ... this week about whether to centralize Inferior vena cava ... competing IVC manufacturer, Cook Medical, have already been centralized ... devices implanted in patients at risk for a pulmonary ... from traveling to the lungs. Claims against Bard and ...
(Date:7/29/2015)... -- ViaCyte, Inc., a privately-held regenerative medicine company with the first stem ... trials, today announced the opening of a second site in its ... T olerability, and E fficacy of VC-01™ Combination P ... is the first in Canada , will be ... , Alberta.  The lead Edmonton ...
Breaking Medicine Technology:Global Neurostimulation Devices Market 2015-2019 2IVC filter litigation continues; law firm provides free information to IVC filter patients 2ViaCyte Announces Second Clinical Trial Site at University of Alberta 2ViaCyte Announces Second Clinical Trial Site at University of Alberta 3ViaCyte Announces Second Clinical Trial Site at University of Alberta 4
... YORK, May 3, 2011 Reportlinker.com announces that a ... Cancer Reports Bundle ... includes the following TriMark Publications reports at a 15% discount off ... Biomarker Technology Platforms for Cancer Diagnoses and Therapies. ...
... 2011 Researchers from the University of Cincinnati presented ... Roentgen Ray Society 2011 Annual Meeting today, demonstrating ... radiation exposure for breast cancer patients.   ... can show the location as well as the metabolic ...
Cached Medicine Technology:Reportlinker Adds Cancer Reports Bundle 2Reportlinker Adds Cancer Reports Bundle 3Reportlinker Adds Cancer Reports Bundle 4Reportlinker Adds Cancer Reports Bundle 5Reportlinker Adds Cancer Reports Bundle 6Reportlinker Adds Cancer Reports Bundle 7Reportlinker Adds Cancer Reports Bundle 8Study Shows Same Day PET-Guided Biopsy May Expedite Pre-Operative Work-up For Breast Cancer Patients and Reduce Radiation Exposure 2
... Designed for High Throughput Screening (HTS), ... assays into HTS by sharing all ... of Analyst AD, fluorescence intensity, fluorescence ... Optimized for seamless integration into robotic ...
... Combines all the right features for ... a simple instrument control. Reduces the ... assays into HTS. Specifically developed to ... laboratories, Analyst AD delivers unparalleled detection ...
... The POLARstar OPTIMA is a fully ... incorporates five different measurement principles:, , ... , Time-Resolved Fluorescence , High-Performance ... Absorbance ,It is designed ...
... DNA Expert: Detection of PCR, cDNA and Oligonucleotides ... optimal microplate reader for a variety applications that ... instrument is suitable to handle assays in ... PCR tubes Cuvettes Independent ...
Medicine Products: